Delveinsight

JULY 24, 2021

The necessity of a robust Angelman syndrome pipeline is indispensable at the current moment because of a shortage of any approved therapy option available in the market. Companies like Roche , Biogen , Ovid therapeutics , and Ionis , are among several companies that are finding potential cure taking forward Angelman syndrome market.

Gene Therapy 96

Gene Therapy Gene Gene Expression RNA 96

Delveinsight

JANUARY 18, 2021

The present Angelman syndrome treatment market revolves around the management of symptoms rather than curing the condition. . Several pharmaceutical and biotech companies in the Angelman syndrome market are exploring the novel curative approaches. These biomarkers could then be used to check if a drug affects AS.

Marketing 52

Marketing Gene Drugs Protein 52

Pharma Marketing Network

DECEMBER 21, 2020

A herculean effort will be required from pharmaceutical marketers of all stripes, but particularly those in the promotional medical education (promo med-ed) space, to address the many challenges. This relinquishes many of the perceived benefits of RNAi therapies that distinguish them from gene therapy (e.g., Am J Bioeth.

Genetics 52

Genetics Medicine Gene Therapy Marketing 52

Roots Analysis

AUGUST 12, 2024

It is worth mentioning that molecular diagnostics is a subset of the broader in vitro diagnostics market. According to the World Health Organization, there are over 40,000 in vitro diagnostics products available in the market. Such test can be used for gene expression profiling, genotyping and detecting chromosomal abnormalities.

Genetics 40

Genetics Gene Expression RNA DNA 40

pharmaphorum

JANUARY 13, 2022

Recall that KRAS was considered an undruggable target for decades before Amgen found a suitable binding region on the protein and bought an inhibitor to market for lung cancer. New R&D techniques that have unlocked the 3D structure of complex molecules have, however, started to render the term obsolete.

Protein 59

Protein Gene Expression Gene Regulation 59

XTalks

MARCH 7, 2024

Industry professionals will explore the market, innovative formulations and nutritional solutions tailored to empower women toward optimal health and well-being. A significant 58 percent of women worldwide have heightened their use of supplements to support overall wellness.

Genetics 115

Genetics Hormones Genome Genomics 115

XTalks

MARCH 13, 2024

Related: Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments — Featuring Pierre Simon, VP Marketing, Sight Sciences – Xtalks Life Science Podcast Ep. Secondly, other funded research is exploring differential gene expression regulated by DNA methylation.

Gene Therapy 111

Gene Therapy Gene Life Science DNA 111

The Pharma Data

DECEMBER 14, 2020

“We believe aligning with one of the largest and fastest growing companies in China’s NGS-based cancer therapy selection market speaks to the strength of DetermaRx as a valuable treatment stratification tool to help clarify this critical treatment decision point in early stage tumors. About Burning Rock.

Licensing 52

Licensing Licensing Marketing Gene Expression 52

Roots Analysis

AUGUST 31, 2023

At present, extensive studies are being conducted to understand the interaction between nutrients and gene expression at the molecular level, to determine the effect of a specific nutrient and dietary regime on human health. In part, the success of the Human Genome Project has also paved a path for the novel concept of nutrigenomics.

Genome 40

Genome Genomics Genetics Gene 40

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: IgG gene expressing animal models. Regeneron Pharmaceuticals is the leading patent filer in IgG gene expressing animal models.

Gene Expression 130

Gene Expression Gene Genetic Engineering Antibody 130

Roots Analysis

NOVEMBER 3, 2023

NAD + is involved in a wide range of cellular processes, including energy metabolism, DNA repair, and gene expression. Developing new drugs is a costly and time-consuming process, and many promising drugs fail to make it to market due to financial constraints.

Development 40

Development Drugs Trials FDA Approval 40

The Pharma Data

NOVEMBER 9, 2020

The length of time that it takes for Amgen to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and Amgen expects similar variability in the future. Amgen may not be able to access the capital and credit markets on terms that are favorable to it, or at all. EMJ Allergy Immunol.

Trials 52

Trials Production Sales Manufacturing 52

XTalks

MARCH 22, 2021

The mega biotech acquisition deals, ranging between a quarter to over half a billion dollars, reflects the expanding oncology market, which was valued at $136.7 Despite setbacks due to the pandemic, the market is expected to recover and continue its march forward. The liquid biopsy market itself was valued at over $1.06

Life Science 110

Life Science Development Marketing Gene Expression 110

pharmaphorum

JANUARY 29, 2021

ZFPs can also be engineered to make ZFP transcription-factors, or ZFP-TFs, which are proteins that can be used to regulate genomes by selectively increasing or decreasing gene expression. Zinc fingers are the most common control gene in the body,” Macrae explains. “We The exact mechanism depends on the disease in question.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

FEBRUARY 9, 2021

InteRNA is focusing on the development of gene-silencing drugs based on microRNA, naturally occurring, non-coding strands of RNA that are thought to regulate gene expression in cells.

Trials 59

Trials Gene Silencing RNA Gene Expression 59

Roots Analysis

OCTOBER 22, 2023

Coding RNAs include messenger RNA (mRNA) and short interfering RNA (siRNA), which encode proteins and silence gene expression, respectively. RNA interference (RNAi) Therapeutics : Fundamentally, RNAi is a natural process of post-transcriptional gene silencing, involving short strands of nucleic acids.

RNA 40

RNA Protein Genetics Gene Expression 40

The Pharma Data

AUGUST 3, 2021

Istodax remains on the market for treatment of patients with cutaneous T-cell lymphoma (CTCL) who have received at least one prior systemic therapy. HDACs catalyze the removal of acetyl groups from acetylated lysine residues in histones, resulting in the modulation of gene expression.

In-Vitro 52

In-Vitro Nurses Gene Expression Medicine 52

Roots Analysis

JANUARY 14, 2024

Usually, the desired gene, such as human insulin gene, when inserted into the plasmid of the host cell uses transcriptional and translational machinery of the host to express itself. It is worth mentioning that in vitro gene expression requires a suitable host for the production of a specific gene product.

Contract Manufacturing 40

Contract Manufacturing Protein Manufacturing Production 40

Delveinsight

JULY 30, 2020

Omega’s platform is designed to adjust gene expression to healthy levels rather than switching genes on and off. The work of the company is based on the genes and their regulatory elements found in loops of DNA called Insulated Genomic Domains (IGDs). GSK culls a host of pipeline meds after failures, prioritization.

Genome 52

Genome Genomics Antibody Gene 52

XTalks

DECEMBER 24, 2020

But there are glimmers of hope — the COVAX advanced market commitment provides the mechanism for countries to access, at least for the first 20 percent of their population, a pretty significant supply of vaccines.”. Dr. Omer says, “it would be a tragedy if the disparities in resources translate into disparities to access to vaccines.

Life Science 111

Life Science Vaccination Vaccine Gene 111